Allergan dives into CRISPR-Cas9

被引：1
|
作者：
不详
机构：
来源：
NATURE BIOTECHNOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1038/nbt0417-296
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [41] Energy biotechnology in the CRISPR-Cas9 era
    Estrela, Raissa
    Cate, Jamie Harrison Doudna
    CURRENT OPINION IN BIOTECHNOLOGY, 2016, 38 : 79 - 84
  • [42] CRISPR-Cas9 Checkpoint Makes the Cut
    不详
    CHEMICAL ENGINEERING PROGRESS, 2017, 113 (09) : 5 - 5
  • [43] Modeling cancer processes with CRISPR-Cas9
    Lu, Xiao-Jie
    Qi, Xiaolong
    Zheng, Dong-Hui
    Ji, Li-Juan
    TRENDS IN BIOTECHNOLOGY, 2015, 33 (06) : 317 - 319
  • [44] Application of CRISPR-Cas9 in eye disease
    Wu, Wenyi
    Tang, Luosheng
    D'Amore, Patricia A.
    Lei, Hetian
    EXPERIMENTAL EYE RESEARCH, 2017, 161 : 116 - 123
  • [45] CRISPR-Cas9 for reporter insertions in mouse
    Nature Methods, 2013, 10 (11) : 1055 - 1055
  • [46] Multidimensional chemical control of CRISPR-Cas9
    Moore, Christopher L.
    Maji, Basudeb
    Choudhary, Amit
    Shoulders, Matt
    FASEB JOURNAL, 2017, 31
  • [47] CRISPR-Cas9 genome engineering revolution
    Doudna, Jennifer
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [48] Who owns CRISPR-Cas9 in Europe?
    Kupecz, Andra
    NATURE BIOTECHNOLOGY, 2014, 32 (12) : 1194 - 1196
  • [49] CRISPR-Cas9 and the Promise of a Better Future
    Lucia Raposo, Vera
    EUROPEAN JOURNAL OF HEALTH LAW, 2019, 26 (04) : 308 - 329
  • [50] Target specificity of the CRISPR-Cas9 system
    Xuebing Wu
    Andrea JKriz
    Phillip ASharp
    Quantitative Biology, 2014, 2 (02) : 59 - 70
12345